Survival among the older adults with clinical signs of Lewy body dementia in 40 Swedish nursing homes: a 6-year follow-up study

被引:1
作者
Zahirovic, Iris [1 ]
Torisson, Gustav [1 ]
Wattmo, Carina [1 ]
Londos, Elisabet [1 ]
机构
[1] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Lund, Sweden
来源
BMJ OPEN | 2019年 / 9卷 / 05期
基金
瑞典研究理事会;
关键词
ANTIPSYCHOTIC MEDICATIONS; ALZHEIMERS-DISEASE; BODIES; PREVALENCE; MANAGEMENT; DIAGNOSIS; DLB; PARKINSONISM; SYMPTOMS; EFFICACY;
D O I
10.1136/bmjopen-2018-028010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To investigate survival among elderly residents of Swedish nursing homes (NHs), with specific focus on those with two or more signs of Lewy body dementia (LBD). Design Prospective observational study. Setting NHs in Malmo, the third largest city in Sweden. Participants The study population was older adults (aged >= 65 years) living in the 40 NHs in Malmo. Clinical data were collected with a customised questionnaire assessing core clinical LBD signs. Patients were categorised based on 0-1 or 2-4 LBD signs. The head nurse at each NH collected the study data: LBD questionnaires, electronic medication lists and electronic medical records from 2012 to 2013. Main outcome measures 80-month mortality. Results Five hundred and fifty-eight (96%) of the residents were deceased at follow-up; among these, mean (95% CI) overall survival time was 29 (28-31) months. Mean survival differed between the LBD groups; those with 0-1 LBD signs lived 8 months longer than those with 2-4 LBD signs. Mortality risk for residents in the LBD 2-4 group was also significantly higher. HR adjusted for age and sex was HR (95% CI) 1.60 (1.30 to 1.97). Mortality risk was also significantly higher in residents with signs of fluctuating cognition 1.36 (1.15 to 1.62), rapid eye movement sleep behaviour disorder 1.49 (1.11 to 1.98), balance problems 1.36 (1.14 to 1.61) or rigidity 1.41 (1.18 to 1.68). Conclusions This large, longitudinal study shows the important survival effects of identifying and diagnosing older adults NH residents who have two or more LBD signs.
引用
收藏
页数:6
相关论文
共 43 条
  • [1] Role of cholinesterase inhibitors in Parkinson's disease and dementia with Lewy bodies
    Aarsland, D
    Mosimann, UP
    McKeith, IG
    [J]. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2004, 17 (03) : 164 - 171
  • [2] Aarsland D, 1999, INT J GERIATR PSYCH, V14, P69, DOI 10.1002/(SICI)1099-1166(199901)14:1<69::AID-GPS888>3.0.CO
  • [3] 2-C
  • [4] Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria
    Aarsland, Dag
    Rongve, Arvid
    Nore, Sabine Piepenstock
    Skogseth, Ragnhild
    Skulstad, Siri
    Ehrt, Uwe
    Hoprekstad, Dagne
    Ballard, Clive
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 26 (05) : 445 - 452
  • [5] Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
    Aarsland, Dag
    Ballard, Clive
    Walker, Zuzana
    Bostrom, Fredrik
    Alves, Guido
    Kossakowski, Katja
    Leroi, Iracema
    Pozo-Rodriguez, Francisco
    Minthon, Lennart
    Londos, Elisabet
    [J]. LANCET NEUROLOGY, 2009, 8 (07) : 613 - 618
  • [6] [Anonymous], 2008, INF HEALTHC PROF CON
  • [7] Improving diagnosis of possible DLB Is there a role for MIBG myocardial scintigraphy?
    Ballard, Clive
    Grimmer, Timo
    [J]. NEUROLOGY, 2013, 81 (20) : 1730 - 1731
  • [8] Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease
    Bostrom, Fredrik
    Jonsson, Linus
    Minthon, Lennart
    Londos, Elisabet
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (02) : 150 - 154
  • [9] Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
    Emre, Murat
    Tsolaki, Magda
    Bonuccelli, Ubaldo
    Destee, Alain
    Tolosa, Eduardo
    Kutzelnigg, Alexandra
    Ceballos-Baumann, Andres
    Zdravkovic, Slobodan
    Bladstrom, Anna
    Jones, Roy
    [J]. LANCET NEUROLOGY, 2010, 9 (10) : 969 - 977
  • [10] Global prevalence of dementia: a Delphi consensus study
    Ferri, CP
    Prince, M
    Brayne, C
    Brodaty, H
    Fratiglioni, L
    Ganguli, M
    Hall, K
    Hasegawa, K
    Hendrie, H
    Huang, YQ
    Jorm, A
    Mathers, C
    Menezes, PR
    Rimmer, E
    Scazufca, M
    [J]. LANCET, 2005, 366 (9503) : 2112 - 2117